Pfizer manuevers to shield Lipitor from generics
TRENTON, N.J. (AP) - Pfizer is getting creative to preserve Lipitor's billions in sales as the cholesterol drug gets generic competition in the U.S. market.
Pfizer is offering unprecedented discounts and incentives for patients, insurers and companies that process prescriptions. The deals will make the brand name as cheap as or cheaper than generics that go on sale Wednesday.
Normally when a drug's patent ends, generics grab nearly all its market share within a year. Pfizer isn't giving up that easy on Lipitor. The drug still brings in nearly $11 billion a year, a sixth of Pfizer's revenue.
Sanford Bernstein analyst Tim Anderson estimates Pfizer can still make a $100 profit on a 90-day supply of Lipitor under the deals. That's about half what it makes now.
RecommendedRecent Facebook Activity
Only On 7
For all the breaking stories happening in your neighborhood and developing stories happening around the world, join Leon Harris and Alison Starling weeknights on ABC7 News at 5 and 11.
TBD Blogs What you need to read
The Market Report
@TBD On Foot
Best of TBD In case you missed it
Redskins cheerleaders, councilmembers, and boxing legends all came out for the annual fundraiser.